# eGenesis

received FDA IND clearance for EGEN-2784, its genetically engineered porcine kidney, to begin a formal clinical trial for end-stage kidney disease, building on an ongoing expanded-access compassionate-use program with reported patient updates.

Source: https://en.bioecon.ru/companies/egenesis/
Updated: 2026-07-03

- Country: United States

## Technologies

- [Xenotransplantation](https://en.bioecon.ru/technology/xenotransplantation/)